Cryptococcosis Market Analysis by Recent Industry Developments, Efficient Procedures & Globalization To 2022-2030

The global cryptococcosis market for the historical period 2017–2018 and forecast period 2019–2027, rise in reported cases of cryptococcosis, surge in number of surgical procedures; overuse of antibiotics, and introduction of new therapies are projected to drive the global cryptococcosis market

Get the sample copy of report@

According to the report, the global cryptococcosis market was valued at US$ 4.7 Bn in 2018 and is anticipated to expand at a CAGR of 4.3% from 2019 to 2030

Increase in Reported Cases of Cryptococcosis: A Key Driver

HIV positive patients are found to be more prevalent for fungal infection. Around 220,000 cases of cryptococcal meningitis are evident to occur among people with HIV/AIDS worldwide each year, resulting in nearly 181,000 deaths. Most cryptococcal meningitis cases occur in sub-Saharan Africa.

According to the Centers for Disease Control and Prevention (CDC) of the U.S., the overall incidence of cryptococcosis was 0.4 to 1.3 cases per 100,000 population and annual incidence among persons with AIDS was between 2 and 7 cases per 1,000; the case-fatality ratio was approximately 12%.

Prevalence of cryptococosis lied majorly in Sub-Saharan countries. However, in recent years, many cases of HIV related cryptococcosis occurred in developed countries such as Australia, U.S. and Germany. The advanced screening processes available in these nations also improve the rate of diagnosis, thereby driving the Cryptococcosis drugs industry. Increased HIV related cryptococcosis infection along with rising initiatives by government and non-government organizations for awareness of available treatment is the major factor that drives the growth of cryptococcosis market.

Improved access to diagnostic facilities to Augment Global Market

Accurate diagnosis of cryptococcosis infection is challenging because of lack of technologies to distinguish C. neoformans and C. gattii infections

Currently available diagnostic technologies require use of examination of DNA or isolation of the fungus using customized culture media. These technologies are time consuming, expensive, and require skilled operators.

However, new technologies such as biomarker detection in blood using immunoassay platforms are being introduced in the market that offer more efficient results. These new technologies are expected to improve diagnosis of cryptococcosis infection. This in turn is likely to drive the cryptococcosis market.

Patent expiry of key drugs and entry of generics to Hamper Global Cryptococcosis Market

The Cryptococcosis market experienced a patent cliff during the last decade. Expiration of patents affects the revenue of pharmaceutical companies. Moreover, generic version of a drug hampers the revenue of branded drug products.

View full report@

This factor is expected to have a profound impact on the cryptococcosis drugs market, causing a decline in market revenue. Moreover, approved ANDAs for most of these molecules will lead to intense generic competition. Increasing number of generic drugs and patent expirations will negatively affect the market. Hence, patent expirations are likely to restrain the Cryptococcosis market.

North America to Account for Major Share of Global Cryptococcosis Market

North America leads the global cryptococcosis market commanding more than 40% share in the global cryptococcosis market. Recent advances in cryptococcosis diagnostics with biomarker test, reimbursement for disease screening, and improved access to antifungal drugs such as flucytosine are the major drivers of the cryptococcosis market in North America. U.S. is the major market in North America. The cryptococcosis market in the U.S. is driven by rising prevalence of cryptococcus gattii in the Pacific Northwest Region of the U.S. Moreover, major factors such as HIV population, highly structured health care industry, and availability of well-defined reimbursement policies from public and private health insurance firms fuel the growth of the cryptococcosis market in the U.S.

Middle East & Africa is the second leading market due to the major contribution of Sub-Saharan countries where the burden of HIV related cryptococcosis infections are very high. Most of the drugs in the region are distributed by non-government organizations. However, the retail pharmacies segment held significant market share in Middle East & Africa.

Global Cryptococcosis Market: Competitive Landscape

This report profiles major players in the global cryptococcosis market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

Purchase Complete Report Now@

Key players operating in the global cryptococcosis market include

  • Bristol-Myers Squibb Company
  • Janssen Biotech, Inc. (Johnson & Johnson)
  • Abbott Laboratories
  • Novartis AG
  • Pfizer, Inc.
  • Valeant Pharmaceuticals, Inc.
  • Glenmark Pharmaceuticals
  • Sigmapharm Laboratories LLC.

Key Questions Answered in Global Cryptococcosis Market Report

  • What is the scope of growth of product companies in the global Cryptococcosis market?
  • What will be the Y-o-Y growth of the global Cryptococcosis market between 2019 and 2027?
  • What is the influence of changing trends in drug treatment on the global Cryptococcosis market?
  • Will North America continue to be the most profitable market for providers of Cryptococcosis treatment products?
  • Which factors will hamper the growth of the global Cryptococcosis market during the forecast period?
  • Which are the leading companies in the global Cryptococcosis market?

Global Cryptococcosis Market – Segmentation


  • Amphotericin B
  • Amphocin
  • Fungizone
  • Other
  • Flucytosine
  • Ancobon
  • Other
  • Fluconazole
  • Diflucan
  • Other
  • Others (Voriconazole, Surgery Treatment, etc.)

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Store
  • Mail Order Pharmacies
  • Others


  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cryptococcosis Market

4. Market Overview

4.1. Introduction

4.1.1. Treatment Type Definition

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Cryptococcosis Market Analysis and Forecast, 2017–2030

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis

5. Market Outlook

5.1. Disease Prevalence & Incidence Rate globally with key countries / Region

5.2. Pipeline Analysis

5.3. Key Industry Developments

6. Global Cryptococcosis Market Analysis and Forecast, by Treatment Type 

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Treatment Type, 2017–2030

6.3.1. Amphotericin B Amphocin Fungizone Other

6.3.2. Flucytosine Ancobon Other

6.3.3. Fluconazole Diflucan Other

6.3.4. Others (Voriconazole, Surgery Treatment, etc.)

6.4. Market Attractiveness, by Treatment Type

7. Global Cryptococcosis Market Analysis and Forecast, by Distribution Channel 

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Distribution Channel, 2017–2030

7.3.1. Hospital Pharmacies

7.3.2. Retail Pharmacies

7.3.3. Drug Store

7.3.4. Mail Order Pharmacies

7.3.5. Others

7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Cryptococcosis Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Market Attractiveness Analysis, by Region

9. North America Cryptococcosis Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. Market Value Forecast By Treatment Type, 2017–2030

9.2.1. Amphotericin B Amphocin Fungizone Other

9.2.2. Flucytosine Ancobon Other

9.2.3. Fluconazole Diflucan Other

9.2.4. Others (Voriconazole, Surgery Treatment, etc.)

9.3. Market Value Forecast, by Distribution Channel, 2017–2030

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Drug Store

9.3.4. Mail Order Pharmacies

9.3.5. Others

9.4. Market Value Forecast, by Country, 2017–2030

9.4.1. U.S.

9.4.2. Canada

9.5. Market Attractiveness Analysis

9.5.1. By Treatment Type

9.5.2. By Distribution Channel

9.5.3. By Country

10. Europe Cryptococcosis Market Analysis and Forecast


Purchase Complete Report Now@

You can place an order or ask any questions, please feel free to contact | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us: